{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:46:51Z","timestamp":1760122011893,"version":"build-2065373602"},"reference-count":64,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["81800779","82170807","81800693","31900821","2016YFC1305600","2016YFC1305602"],"award-info":[{"award-number":["81800779","82170807","81800693","31900821","2016YFC1305600","2016YFC1305602"]}]},{"name":"Major Chronic Non-Communicable Disease Prevention and Control Research, National Key R&amp;D Program of China","award":["81800779","82170807","81800693","31900821","2016YFC1305600","2016YFC1305602"],"award-info":[{"award-number":["81800779","82170807","81800693","31900821","2016YFC1305600","2016YFC1305602"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Women with polycystic ovarian syndrome (PCOS) are more likely to have non-alcoholic fatty liver disease (NAFLD) than non-PCOS women; however, the exact mechanism underlying this trend is unknown. The receptor activator of NF-\u03baB ligand (RANKL) is strongly involved in bone metabolism and has multiple functions. Recent studies suggest that RANKL is implicated in hepatic insulin resistance (IR), which is the highest risk factor for NAFLD. This study aimed to assess the role of RANKL in NAFLD in Chinese women with PCOS. A cross-sectional observational study was conducted on women newly diagnosed with PCOS, which included 146 patients with NAFLD and 142 patients without NAFLD. Sex hormones, glucose, insulin, and lipids were measured, and anthropometric data were collected. The concentration of serum total RANKL was measured using commercial ELISA kits. PCOS patients with NAFLD had a significantly higher mean age, body mass index (BMI), waist circumference (WC), and worsened metabolic profile than non-NAFLD subjects. The concentrations of high-sensitivity C-reactive protein, total cholesterol, and low-density lipoprotein cholesterol increased with the RANKL tertile (p for trend = 0.023, 0.026, and 0.035, respectively). A significantly positive association was found between RANKL (per SD change) and the risks of NAFLD (OR = 1.545, 95% CI = 1.086\u20132.199) after adjusting for confounders, including demographic factors, metabolic markers, and sex hormones. Subgroup multivariate logistic analyses stratified by age, BMI, and WC showed the same tendency. In addition, the positive association between RANKL and NAFLD seemed more prominent in lean patients with a BMI &lt; 24 kg\/m2 (OR = 1.70, 95% CI = 1.06\u20132.75) when compared to overweight\/obesity subjects. Therefore, this study suggests that RANKL is positively associated with the increased risk of NAFLD in Chinese women with PCOS, independent of metabolic and reproductive factors.<\/jats:p>","DOI":"10.3390\/jcm12020451","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T02:20:30Z","timestamp":1672971630000},"page":"451","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["RANKL Is Independently Associated with Increased Risks of Non-Alcoholic Fatty Liver Disease in Chinese Women with PCOS: A Cross-Sectional Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Nan","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Rong","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Xian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Teede, H., Deeks, A., and Moran, L. (2010). Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med., 8.","DOI":"10.1186\/1741-7015-8-41"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J. Endocrinol. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","article-title":"Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters","volume":"40","author":"Durmus","year":"2017","journal-title":"J. Endocrinol. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review","volume":"23","author":"Cariou","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kumarendran, B., O'Reilly, M.W., Manolopoulos, K.N., Toulis, K.A., Gokhale, K.M., Sitch, A.J., Wijeyaratne, C.N., Coomarasamy, A., Arlt, W., and Nirantharakumar, K. (2018). Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002542"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int. J. Obes."},{"key":"ref_9","first-page":"355","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2013.01.041","article-title":"The Origins and Drivers of Insulin Resistance","volume":"152","author":"Johnson","year":"2013","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic Fatty Liver Disease","volume":"346","author":"Angulo","year":"2002","journal-title":"New Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"a031666","DOI":"10.1101\/cshperspect.a031666","article-title":"Regulation of Energy Metabolism by Bone-Derived Hormones","volume":"8","author":"Mera","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ehnert, S., Aspera-Werz, R.H., Ruoss, M., Dooley, S., Hengstler, J.G., Nadalin, S., Relja, B., Badke, A., and Nussler, A.K. (2019). Hepatic Osteodystrophy\u2014Molecular Mechanisms Proposed to Favor Its Development. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102555"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: Bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Takeno, A., Yamamoto, M., Notsu, M., and Sugimoto, T. (2016). Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: A case report. BMC Endocr. Disord., 16.","DOI":"10.1186\/s12902-016-0148-0"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-08-0107","article-title":"Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome","volume":"159","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-10-0720","article-title":"Circulating osteoprotegerin and soluble receptor activator of nuclear factor \u03baB ligand in polycystic ovary syndrome: Relationships to insulin resistance and endothelial dysfunction","volume":"164","author":"Pepene","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_24","first-page":"123","article-title":"AKT2 Gene Polymorphisms, Srankl\/OPG And Hormone Measurements in Polycystic Ovarian Syndrome (PCOS) Women","volume":"3","author":"Aikaterini","year":"2017","journal-title":"Clin. Med. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","article-title":"Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population","volume":"20","author":"Feng","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14397595.2018.1469580","article-title":"Serum levels of proinflammatory, anti-inflammatory cytokines, and RANKL\/OPG in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome","volume":"29","author":"Zhang","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: A novel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: An update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod. Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/hep4.2039","article-title":"Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age","volume":"6","author":"Maldonado","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00125-018-4779-8","article-title":"Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus","volume":"62","author":"Lee","year":"2019","journal-title":"Diabetologia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2020.03.049","article-title":"Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes","volume":"73","author":"Sarkar","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bpobgyn.2016.03.003","article-title":"Hepatic manifestations of women with polycystic ovary syndrome","volume":"37","author":"Chen","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1005681","DOI":"10.3389\/fcell.2022.1005681","article-title":"Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand\/receptor activator of nuclear factor kappa-B signaling","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1007\/s11033-019-04997-z","article-title":"RANK\/RANKL\/OPG pathway is an important for the epigenetic regulation of obesity","volume":"46","author":"Kalkan","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","article-title":"Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism","volume":"11","author":"Weivoda","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","article-title":"Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible role in plaque destabilization","volume":"26","author":"Sandberg","year":"2006","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.106.686774","article-title":"Soluble Receptor Activator of Nuclear Factor-\u03baB Ligand and Risk for Cardiovascular Disease","volume":"116","author":"Kiechl","year":"2007","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"426863","DOI":"10.4061\/2011\/426863","article-title":"Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal Dysfunction","volume":"2011","author":"Karmakar","year":"2011","journal-title":"J. Osteoporos."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6953421","DOI":"10.1155\/2020\/6953421","article-title":"RANKL Is Involved in Runx2-Triggered Hepatic Infiltration of Macrophages in Mice with NAFLD Induced by a High-Fat Diet","volume":"2020","author":"Zhong","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00365513.2010.524933","article-title":"Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease","volume":"70","author":"Yilmaz","year":"2010","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.metabol.2015.12.005","article-title":"Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case\u2013control study in China","volume":"65","author":"Niu","year":"2016","journal-title":"Metabolism"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.diabet.2016.02.004","article-title":"Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults","volume":"42","author":"Monseu","year":"2016","journal-title":"Diabetes Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diabet.2018.10.001","article-title":"Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes","volume":"45","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1586\/17474124.2016.1111758","article-title":"The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update","volume":"10","author":"Sutti","year":"2016","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese","volume":"27","author":"Liu","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016","volume":"288","author":"Zou","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/db12-0858","article-title":"Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism","volume":"62","author":"Musso","year":"2013","journal-title":"Diabetes"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/jgh.13335","article-title":"Oxidized low-density lipoprotein antibodies\/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients","volume":"31","author":"Ampuero","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/jbmr.2229","article-title":"Identification of Novel Transcription Factors in Osteoclast Differentiation Using Genome-wide Analysis of Open Chromatin Determined by DNase-seq","volume":"29","author":"Inoue","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbadis.2018.10.026","article-title":"SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis","volume":"1865","author":"Jie","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"684007","DOI":"10.3389\/fcell.2021.684007","article-title":"Oxymatrine Attenuates Osteoclastogenesis via Modulation of ROS-Mediated SREBP2 Signaling and Counteracts Ovariectomy-Induced Osteoporosis","volume":"9","author":"Jiang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.bbadis.2015.08.018","article-title":"Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation","volume":"1852","author":"Inoue","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2017.05.017","article-title":"Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice","volume":"809","author":"Zheng","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41418-019-0484-5","article-title":"Dual targeting of SREBP2 and ERR\u03b1 by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss","volume":"27","author":"Zheng","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis","volume":"468","author":"Jacob","year":"2010","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41467-021-22734-8","article-title":"RANKL regulates male reproductive function","volume":"12","author":"Andreassen","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/humrep\/del065","article-title":"The human cumulus\u2013oocyte complex gene-expression profile","volume":"21","author":"Assou","year":"2006","journal-title":"Hum. Reprod."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/gme.0b013e3181d5d523","article-title":"TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women","volume":"17","author":"Lu","year":"2010","journal-title":"Menopause"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/13697137.2011.587556","article-title":"Association analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women","volume":"15","author":"Pan","year":"2012","journal-title":"Climacteric"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/451\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:00:42Z","timestamp":1760119242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/2\/451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jcm12020451"],"URL":"https:\/\/doi.org\/10.3390\/jcm12020451","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2023,1,5]]}}}